Percutaneous absorption of potent topical corticosteroids in patients with severe atopic dermatitis

Efficacy and Safety of Baricitinib Combined With Topical Corticosteroids for Treatment of Moderate to Severe Atopic Dermatitis

JAMA Dermatology ◽

10.1001/jamadermatol.2020.3260 ◽

2020 ◽

Vol 156 (12) ◽

pp. 1333 ◽

Cited By ~ 2

Author(s):

Kristian Reich ◽

Kenji Kabashima ◽

Ketty Peris ◽

Jonathan I. Silverberg ◽

Lawrence F. Eichenfield ◽

...

Keyword(s):

Atopic Dermatitis ◽

Efficacy And Safety ◽

Low basal serum cortisol in patients with severe atopic dermatitis: potent topical corticosteroids wrongfully accused

Yearbook of Dermatology and Dermatologic Surgery ◽

10.1016/s0093-3619(08)70710-x ◽

2008 ◽

Vol 2008 ◽

pp. 56-57

Author(s):

B.H. Thiers

Keyword(s):

Atopic Dermatitis ◽

Serum Cortisol ◽

Topical Corticosteroids ◽

Basal Serum

Use of Topical Corticosteroids with Tralokinumab in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from the 32-Week, Phase 3 ECZTRA 3 Trial

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.4.supp.99 ◽

2020 ◽

Vol 4 (6) ◽

pp. s99

Author(s):

Jonathan Silverberg ◽

Andrew Pink ◽

Christina Olsen ◽

Stephan Weidinger

Keyword(s):

Atopic Dermatitis ◽

Adult Patients ◽

Phase 3 ◽

Abstract not available.

Safety and Efficacy of Upadacitinib in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic Dermatitis: Results From a Pivotal Phase 3, Randomised, Double-Blind, Placebo-Controlled Study (AD Up)

SSRN Electronic Journal ◽

10.2139/ssrn.3748383 ◽

2020 ◽

Author(s):

Kristian Reich ◽

Henrique D. Teixeira ◽

Marjolein de Bruin-Weller ◽

Thomas Bieber ◽

Weily Soong ◽

...

Keyword(s):

Atopic Dermatitis ◽

Controlled Study ◽

Phase 3 ◽

Pivotal Phase ◽

Double Blind ◽

Safety And Efficacy ◽

Double Blind Placebo ◽

Topical Corticosteroids ◽

Adolescents And Adults

26839 Dupilumab with topical corticosteroids results in rapid and sustained improvement in adults with moderate-to-severe atopic dermatitis across all anatomic regions over 52 weeks

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2021.06.489 ◽

2021 ◽

Vol 85 (3) ◽

pp. AB118

Author(s):

Andrew Blauvelt ◽

Marjolein de Bruin-Weller ◽

Melinda Gooderham ◽

David M. Pariser ◽

Eric L. Simpson ◽

...

Keyword(s):

Atopic Dermatitis ◽

Sustained Improvement ◽

Baricitinib improves symptoms in patients with moderate-to-severe atopic dermatitis and inadequate response to topical corticosteroids: patient-reported outcomes from two randomized monotherapy phase III trials

Journal of Dermatological Treatment ◽

10.1080/09546634.2020.1839008 ◽

2020 ◽

pp. 1-10

Author(s):

K. Reich ◽

A. M. DeLozier ◽

F. P. Nunes ◽

J. P. Thyssen ◽

L. F. Eichenfield ◽

...

Keyword(s):

Atopic Dermatitis ◽

Patient Reported Outcomes ◽

Phase Iii ◽

Inadequate Response ◽

Topical Corticosteroids ◽

Patient Reported ◽

Phase Iii Trials

Tralokinumab plus topical corticosteroids for the treatment of moderate‐to‐severe atopic dermatitis: results from the double‐blind, randomized, multicentre, placebo‐controlled phase III ECZTRA 3 trial

British Journal of Dermatology ◽

10.1111/bjd.19573 ◽

2020 ◽

Cited By ~ 2

Author(s):

J.I. Silverberg ◽

D. Toth ◽

T. Bieber ◽

A.F. Alexis ◽

B.E. Elewski ◽

...

Keyword(s):

Atopic Dermatitis ◽

Phase Iii ◽

Double Blind ◽

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

The Lancet ◽

10.1016/s0140-6736(17)31191-1 ◽

2017 ◽

Vol 389 (10086) ◽

pp. 2287-2303 ◽

Cited By ~ 364

Author(s):

Andrew Blauvelt ◽

Marjolein de Bruin-Weller ◽

Melinda Gooderham ◽

Jennifer C Cather ◽

Jamie Weisman ◽

...

Keyword(s):

Atopic Dermatitis ◽

Phase 3 ◽

Topical Corticosteroids ◽

Double Blinded ◽

Term Management

28032 Rapid itch improvement with upadacitinib with or without concomitant topical corticosteroids (TCS) in moderate-to-severe atopic dermatitis (AD): Results from 3 phase 3 studies (Measure Up 1, Measure Up 2, and AD Up)

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2021.06.697 ◽

2021 ◽

Vol 85 (3) ◽

pp. AB171

Author(s):

Andrew Blauvelt ◽

Michael R. Ardern-Jones ◽

Thomas Bieber ◽

Chih-ho Hong ◽

Chia-Yu Chu ◽

...

Keyword(s):

Atopic Dermatitis ◽

Phase 3 ◽

Topical Corticosteroids and Topical Calcineurin Inhibitors in the Treatment of Atopic Dermatitis: Focus on Percutaneous Absorption

American Journal of Therapeutics ◽

10.1097/mjt.0b013e31818a975c ◽

2009 ◽

Vol 16 (3) ◽

pp. 264-273 ◽

Cited By ~ 26

Author(s):

David Pariser

Keyword(s):

Atopic Dermatitis ◽

Percutaneous Absorption ◽

Calcineurin Inhibitors ◽

Topical Corticosteroids ◽

Topical Calcineurin Inhibitors